Swati Dumitras

Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data

Thierry Wendling, Nikolaos Tsamandouras, Swati Dumitras et al. · The AAPS Journal · 2015 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics

Thierry Wendling, Swati Dumitras, Kayode Ogungbenro et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2015 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Model-Based Evaluation of the Impact of Formulation and Food Intake on the Complex Oral Absorption of Mavoglurant in Healthy Subjects

Thierry Wendling, Kayode Ogungbenro, Etienne Pigeolet et al. · Pharmaceutical Research · 2014 · 19 citations

Pharmacy, Nutritional Sciences, Pharmacokinetics +17

Effect of cimetidine, a model drug for inhibition of the organic cation transport (OCT2/MATE1) in the kidney, on the pharmacokinetics of glycopyrronium

Swati Dumitras, Romain Séchaud, Anton Drollmann et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 19 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects

Anne Gardin, Cathy Gray, Srikanth Neelakantham et al. · European Journal of Clinical Pharmacology · 2018 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +9